| Karen Coombs-marcey, RPH | |
|
11300 Mael St, Anchorage, UT 99516 | |
| (907) 346-2363 | |
| Not Available |
| Full Name | Karen Coombs-marcey |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 11300 Mael St, Anchorage, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164796389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0694 (Alaska) | Primary |
| 183500000X | Pharmacist | 145572-1701 (Utah) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Coombs-marcey, RPH 11300 Mael St, Anchorage, UT 99516 Ph: (907) 346-2363 | Karen Coombs-marcey, RPH 11300 Mael St, Anchorage, UT 99516 Ph: (907) 346-2363 |
News Archive
By combining two treatment strategies, both aimed at boosting the immune system's killer T cells, Johns Hopkins researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own.
Boston Scientific Corporation has announced the launch of its TAXUS Liberte Paclitaxel-Eluting Coronary Stent System in Japan.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
Scientists have used DNA sequencing for the first time to effectively track the spread of, and ultimately contain, an outbreak of methicillin-resistant Staphylococcus aureus (MRSA), according to new research published in The Lancet Infectious Diseases.
› Verified 4 days ago